Pubmed CV available at https://www.ncbi.nlm.nih.gov/myncbi/marius.coetzee.1/bibliography/public/

1. Coetzee MJ, Bartleet SC, Ramsay M, Jenkins T. Glucose-6-phosphate dehydrogenase (G6PD) electrophoretic variants and the PvuII polymorphism in southern African populations. Human Genetics 1992;98:111-114.
2. Coetzee MJ, Badenhorst PN, De Wet JI, Joubert G. Haematological condition of the San (Bushmen) relocated from Namibia to South Africa. S Afr Med J 1994; 84:416-420.
3. Emmerich J, Chadeuf G, Coetzee MJ, Alhenc-Gelas M, Fiessinger J-N, Aiach M. A phenylalanine 402 to leucine mutation is responsible for a stable inactive conformation of antithrombin. Thrombosis Research 1994; 76:307-315.
4. Coetzee MJ, Badenhorst PN, Le Roux EP, Doman MJ. Haematology outreach clinics in the Free State and Northern Cape. S Afr Med J 1998; 88(6):702-706.
5. Vosloo WM, Coetzee MJ, Pretorius GHJ. Haemophilia A carrier detection in the Free State and Northern Cape. S Afr Med J 1999; 89:625-626.
6. Coetzee MJ. The use of topical crushed tranexamic acid tablets to control bleeding after dental surgery and from skin ulcers in haemophilia. Haemophilia July 2007:13(4): 443-444.
7. Alli A, Coetzee M, Louw V, Van Rensburg B, Rossouw G, Thompson L, Thein SL. Sickle cell disease in a carrier with pyruvate kinase deficiency. Hematology 2008;13(6):369-372.
8. Coetzee MJ, Louw VJ, Gartrell K, Viljoen CD. Chakalaka-induced vasodilatation in patients with chronic myeloid leukaemia on tyrosine kinase inhibitors. S Afr Med J 2009;99(12):870-871
9. Mahlangu JN, Coetzee MJ, Laffan M, Windyga J, Yee TT, Schroeder J, Haaning J, Siegel JE and Lemm G. Phase I, randomized, double-blind, placebo-controlled, single-dose escalation study of the recombinant factor VIIa variant BAY 86-6150 in hemophilia. Journal of Thrombosis and Haemostasis 2012;10(5): 773–780.
10. Alli NA, Patel M, Alli HD, Bassa F, Coetzee MJ, Davidson A, Essop MR, Lakha A, Louw VJ, Novitzky N, Philip V, Poole JE, Wainwright R. Recommendations for the management of sickle cell disease in South Africa. S Afr Med J 2014;104(11): 743-751.
11. Weyers R, Coetzee MJ, Nel M. Iron status determination in pregnancy using the Thomas plot. International Journal of Laboratory Hematology. 2016;38(2):119-24.
12. Coetzee MJ, Joubert G, Swart M, Streicher A, Kruger M, Koekemoer H. An audit of the completion of bone marrow specimen request forms at an academic laboratory. Medical Technology SA 2017;31:1-6.
13. Thomson J, Hofmann A, Barrett CA, Beeton A, Bellairs GRM, Boretti L, Coetzee MJ, Farmer S, Gibbs MW, Gombotz HH, Hilton C, Kassianides C, Louw VJ, Lundgre, C, Mahlangu JN, Noel CB, Rambiritch V, Schneider F, Verburgh E, Wessels P-L, Wessels P, Wise R, Shander A. on behalf of the South African Patient Blood Management Group. Patient blood management: A solution for South Africa. S Afr Med J 2019;109(7):471-6.
14. Bailly J, Louw S, De Koker A, et al. Guidelines for lupus anticoagulant testing in South Africa. The Journal of Medical Laboratory Science & Technology South Africa 2020;2(1):6-12.
15. Coetzee MJ, Van Marle AC. Response to “Efficacy of oral iron therapy in geophagic women with iron deficiency anaemia residing in Botshabelo, South Africa”. Journal of Laboratory Medical Technology of South Africa 2020;2(2):114-5.
16. Mutize TT, Seedat RY, Ploos van Amstel JK, et al. The clinical and genetic features of hereditary haemorrhagic telangiectasia (HHT) in central South Africa-three novel pathogenic variants. Mol Biol Rep 2020;47:9967–72. http://dx.doi.org/10.1007/s11033-020-05985-4
17. van Marle AC, Acho P-M, Chepape CO, et al. A retrospective file audit of preoperative anaemia in patients referred to the Universitas Academic Hospital Anaesthesiology Clinic before elective orthopaedic surgery. South African Orthopaedic Journal (in press).
18. Koekemoer HT, Joubert J, Nichol RJ, Joubert G, Coetzee MJ. Mental health disorders and health-related quality of life in adults with inherited bleeding disorders in central South Africa. Haemophilia 2022. http://dx.doi.org/10.1111/hae.14486

• Haemophilia and bleeding disorders
• Hereditary haemorrhagic telangiectasia
• Patient blood management

Special interests: Haemophilia and bleeding disorders, local haematological problems, hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu diease or HHT), patient blood management
 

• MBChB: MHAE2724 (Haematology and Immunology) and MCLI2720 Clinical Skills in 2nd year, Integrated Medical Assessments (MIMA3713) in the 2nd and 3rd year, and the haematology components of Internal Medicine from th 3rd to 5th years
• MMed(Haematology) – training of specialist haematologists
• MPhil(Clinical Haematology)
• BMedSc(Hons)(Haematology)

• Haematology Clinic Univeristas Hospital
• South Africa Haemophilia Foundation advocacy
• Bloemfontein Haemophilia Treatment Centre
• Kimberley Haemophilia Treatment Centre Outreach Clinic